Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
san diego blog main
4
×
san diego top stories
boston blog main
boston top stories
clinical trials
gene therapy
national top stories
new york blog main
san diego
san francisco blog main
startups
vc
abide therapeutics
acetylon pharmaceuticals
allergan
alnylam
ambys medicines
amylin pharmaceuticals
arena pharmaceuticals
artie suckow
astellas pharma
atlas venture
audentes therapeutics
avidity biosciences
ben cravatt
bluebird bio
boston
botox
bristol-myers squibb
cell therapy
constellation pharmaceuticals
deals
drug delivery
dtx pharma
duchenne muscular dystrophy
dyne therapeutics
epilepsy
What
diseases
4
×
medicines
4
×
new
therapeutics
treat
abide
advance
ago
aiming
ambys
appointed
big
biologics
biotech
biotechs
chief
considered
considering
control
data
deadly
deal
debuted
deliver
developing
drug
drugs
dtx
dyne
early
executive
expected
experimental
eyes
finney
formed
future
genetic
having
hitting
Language
unset
Current search:
medicines
×
diseases
×
" san diego blog main "
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs
@xconomy.com
5 years ago
Former Zavante Executive Tapped as Abide Therapeutics President
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
